University School of Physical Education in Cracow
Krakow, 31-571, Poland
NCT Number: NCT06043089
Several previous studies observed a positive effect of beetroot supplementation on sports performance in athletes, mainly in endurance performance. However, less attention has been paid to its effects on short-duration performance, especially in youth athletes. Moreover, only a few previous investigations performed biochemical analyses, including pro-oxidant balance assessments. It is especially important because chronic nitrate intake might directly cause the production of reactive nitrogen species and reactive oxygen species in other subcellular compartments, leading to more oxidative stress. Additionally, no previous study verified the impact of beetroot intake on sleep.
Looking for future studies?
Notify Me14 year–23 year
Male
Interventional
Not applicable
Krakow, 31-571, Poland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Athletes received 7 days of beetroot juice supplementation with nitrate supplementation (2 × 70 mL of beetroot juice ∼12.9 mmol NO3-; Beet It, James White Drinks, Ipswich, UK) or placebo (2 × 70 mL of water with beetroot powder with negligible nitrate content).
Time frame: 7 days after treatment
yo-yo intermittent recovery test level 1
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure nitrate concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure nitrite concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure total oxidative status
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure total antioxidant capacity
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
The oxidative stress index will be calculated as the ratio of plasma prooxidant to antioxidant status
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure 3-nitrotyrosine concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure advanced protein oxidation products concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure ox-8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood plasma will be obtained to measure thiobarbituric acid reactive substances concentration
Time frame: 1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test
Arterialized blood will be obtained to measure lactate concentration
Time frame: nights 1 - 7 during treatment
Total time spent in bed during the night assessed by sleep radar
Time frame: nights 1 - 7 during treatment
The time it takes from when the athlete intends to go to sleep and actually starts to sleep assessed by sleep radar
Time frame: nights 1 - 7 during treatment
Total sleep time obtained from sleep onset to time at wake-up assessed by sleep radar
Time frame: nights 1 - 7 during treatment
Total amount of time in light sleep assessed by sleep radar
Time frame: nights 1 - 7 during treatment
Total amount of time in deep sleep assessed by sleep radar
Time frame: nights 1 - 7 during treatment
Total amount of time in REM sleep assessed by sleep radar
Time frame: nights 1 - 7 during treatment
The percentage of total sleep time to lights off and leaving bed assessed by sleep radar
Time frame: 7 days after treatment
Time frame: 7 days after treatment
Time frame: 7 days after treatment
Time frame: 7 days after treatment
Time frame: 7 days after treatment
Time frame: 7 days after treatment
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure myoglobin concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure creatine kinase activity
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure C-reactive protein concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Whole blood will be obtained to measure leukocyte count
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure testosterone concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure cortisol concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure creatinine concentration
Time frame: 1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test
Blood serum will be obtained to measure uric acid concentration
Time frame: 1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test
Arterialized blood will be obtained to measure hemoglobin concentration
Time frame: 1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test
Arterialized blood will be obtained to measure hematocrit
Time frame: 1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test
The change in plasma volume will be calculated using the hemoglobin and hematocrit results
University School of Physical Education, Krakow, Poland
Other
Impact of Beetroot Supplementation on Sports Performance, Prooxidant-antioxidant Balance and Sleep in Athletes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details